MDM2 and CDK4 gene amplification in Ewing's sarcoma

The Journal of Pathology

Volumn 175, Issue 2, 1995, Pages 211-217

  Ladanyi, Marc ^a   Lewis, Ronald ^a   Jhanwar, Suresh C ^a   Gerald, William ^a   Huvos, Andrew G ^a   Healey, John H ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

CDK4; Ewing's sarcoma; gene amplification; MDM2; p53; peripheral neuroectodermal tumour

Indexed keywords

PROTEIN P53;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; EWING SARCOMA; FEMALE; GENE AMPLIFICATION; HUMAN; HUMAN TISSUE; MALE; NEUROECTODERM TUMOR; PRIORITY JOURNAL; SOUTHERN BLOTTING;

ADOLESCENT; ADULT; BLOTTING, SOUTHERN; BONE NEOPLASMS; CHILD; CHILD, PRESCHOOL; FEMALE; GENE AMPLIFICATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMAN; MALE; NEUROECTODERMAL TUMORS, PRIMITIVE, PERIPHERAL; PROTEIN P53; PROTO-ONCOGENE PROTEINS; SARCOMA, EWING'S; SUPPORT, NON-U.S. GOV'T; TUMOR CELLS, CULTURED;

EID: 0028955652     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.1711750209     Document Type: Article

References (42)

1. Amplification of a gene encoding a p53‐associated protein in human sarcomas
2. The mdm‐2 oncogene product forms a complex with the p53 protein and inhibits p53‐mediated transactivation
3. The p53‐mdm2 autoregulatory feedback loop: a paradigm for the regulation of growth control by p53?
4. Tumorigenic potential associated with enhanced expression of a gene that is amplified in a mouse tumor cell line
5. The mdm‐2 oncogene can overcome wild‐type p53 suppression of transformed cell growth
6. Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53
7. p53 mutation and MDM2 amplification in human soft tissue sarcomas
8. MDM2 gene amplification in metastatic osteosarcoma
9. Ewing's sarcoma is an undifferentiated neuroectodermal tumor
10. Neural differentiation in small round cell tumors of bone and soft tissue with the translocation t(11;22)(q24;q12). An immunohistochemical study of 11 cases
11. EWS rearrangement in Ewing's sarcoma and peripheral neuroectodermal tumor. Molecular detection and correlation with cytogenetic analysis and MIC2 expression
12. Amplification of cellular oncogenes: a predictor of clinical outcome in human cancer
13. Coamplification of the CDK4 gene with MDM2 and GLI in human sarcomas
14. Translocation involving chromosome 22 in Ewing's sarcoma: a cytogenetic study of four fresh tumors
15. Chromo‐some study of Ewing's sarcoma (ES) cell lines. Consistency of a reciprocal translocation t(11:22)(q24;q12)
16. Gene fusion with an ETS DNA‐binding domain caused by chromosome translocation in human tumours
17. Cloning and characterization of the Ewing's sarcoma and peripheral neuroepithelioma t(11;22) translocatinom breakpoints
18. Chromosomes in Ewing's sarcoma. I. An evaluation of 85 cases and remarkable consistency of t(11;22)(q24;q12)
19. Amplification and overexpression of the MDM2 gene in a subset of human malignant gliomas without p53 mutations
20. MDM2 gene amplification correlates with ring chromosomes in soft tissue tumors
21. Infrequency of MDM2 gene amplification in pediatric solid tumors and lack of association with p53 mutations in adult squamous cell carcinomas
22. Absence of amplification of MDM2 gene, a regulator of p53 function, in myelodysplastic syndromes
23. Lack of MDM2 amplification in human leukaemia
24. T(11;22) and other chromosomal rearrangements in Ewing's sarcoma
25. Histological and cytogenetic findings in a malignant tumor of the chest wall and lung (Askin tumor)
26. Mutations of the p53 gene are involved in Ewing's sarcomas but not in neuroblastomas
27. Narrow spectrum of infrequent p53 mutations and absence of MDM2 amplification in Ewing tumours
28. p53 mutations in human tumors with chimeric EWS/FLI‐1 genes
29. Expression of p53 in human neuroblastoma‐ and neuroepithelioma‐derived cell lines
30. Mammalian G1 cyclins
31. WAF1, a potential mediator of p53 tumor suppression
32. The p21 Cdk‐interacting protein Cip1 is a potent inhibitor of G1 cyclin‐dependent kinases
33. A cell cycle regulator potentially involved in genesis of many tumor types
34. Deletions of the cyclin‐dependent kinase‐4 inhibitor gene in multiple human cancers
35. p27kipl, a cyclin‐Cdk inhibitor, links transforming growth factor‐β and contact inhibition to cell cycle arrest
36. TGF beta inhibition of Cdk4 synthesis is linked to cell cycle arrest
37. Expression of transforming growth factor‐β isoforms in small round cell tumors of childhood
38. Mapping of amplification units in the q13–;14 region of chromosome 12 in human sarcomas: some amplica do not include MDM2
39. Ewing's sarcoma. Prognostic factors, disease control, and the reemerging role of surgical treatment
40. Gene amplification and tumor progression
41. Association of multiple copies of the N‐myc oncogene with rapid progression of neuroblastomas
42. Amplification and overexpression of the erbB‐2 gene in human tumors: its involvement in tumor development, significance as a prognostic factor, and potential as a target for cancer therapy